PARP1 and cancer: Therefore, it has been hypothesised that NNMT overexpression and subsequent reduction of intracellular nicotinamide in cancer stem cells removes PARP inhibition, conferring improved survival characteristics of cancer stem cells against DNA damage and programmed cell death [77].